%0 Journal Article
%T Pembrolizumab plus single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma.
%A Suzuki K
%J Lancet Haematol
%V 11
%N 7
%D 2024 Jul
%M 38937020
%F 30.153
%R 10.1016/S2352-3026(24)00168-6